United States

People: Imv Inc (IMV.TO)

IMV.TO on Toronto Stock Exchange

18 Jan 2019
Change (% chg)

$0.12 (+1.59%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Ors, Frederic 

Mr. Frederic Ors is Chief Executive Officer, Director of ImmunoVaccine Inc., He spent 13 years at Medicago Inc. in Quebec, most recently as vice-president of business development and strategic planning. He has been an integral part of Medicago's success in securing multiple non-dilutive financing opportunities, leading to an acquisition by Mitsubishi Pharma in 2013 for $357-million. Before joining Medicago, he was manager of intellectual property and licensing for Paris Diderot University, a complex of 150 labs, two hospitals and 2,300 scientists in Paris. He earned his bachelor's degree in biology and his master's degree in management of innovation projects in biotechnology at the University of Angers.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --